StockData
Harmony Biosciences Holdings, Inc. logo

Harmony Biosciences Holdings, Inc. (HRMY) KPIs and segments

HRMYNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 18/3039% below fair value
$33.01+0.05 (+0.15%)

Close on Nov 17, 2026Market cap $1.92BP/E 10.7Yield –

KPIs & segments

Operating metrics and segments that drive Harmony Biosciences's business

Coming soon

This tab will track the numbers specific to Harmony Biosciences's business model — such as store count, revenue by banner, revenue per store and new openings — taken from filings and earnings releases.

See a number that looks wrong?